Compare IRS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | NBTX |
|---|---|---|
| Founded | 1943 | 2003 |
| Country | Argentina | France |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1994 | 2020 |
| Metric | IRS | NBTX |
|---|---|---|
| Price | $15.27 | $22.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 177.6K | 50.1K |
| Earning Date | 11-06-2025 | 09-30-2025 |
| Dividend Yield | ★ 9.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $370,153,377.00 | $11,930,711.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $136.64 |
| P/E Ratio | $3.46 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.61 | $2.82 |
| 52 Week High | $17.29 | $30.35 |
| Indicator | IRS | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.84 | 56.89 |
| Support Level | $14.80 | $20.83 |
| Resistance Level | $15.77 | $23.77 |
| Average True Range (ATR) | 0.59 | 0.82 |
| MACD | -0.07 | 0.16 |
| Stochastic Oscillator | 71.74 | 74.57 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.